Condensed Interim Unaudited Financial Statements for the six month period ended 31 May 2021
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement | Business Wire
A1VQDB | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,625 % bis 15.10.2028 | finanzen.net
A280F4 | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 6,000 % bis 31.01.2025 | finanzen.net
Teva Pharmaceutical Finance Netherlands II B.V. (Director) - Curaçao
A190FK | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 4,500 % bis 01.03.2025 | finanzen.net
Barcode No-Print Zone
Company Announcement For immediate release Teva Pharmaceutical Finance Netherlands II B.V. Piet Heinkade 107, 1
Teva Pharmaceutical Industries Pharmaceutical Industry Teva Pharmaceuticals USA, Inc. Teva Canada Teva Pharmaceutical Finance Netherlands III B.V., PNG, 827x354px, Teva Pharmaceutical Industries, Biosimilar, Brand, Corporation, Generic Drug Download Free
Teva Logistics Services BV 34353519
Teva Pharmaceutical Finance Netherlands III B.V. Teva Pharmaceutical Finance Netherlands II B.V.
Most Active Foreign Bonds 11.10.2021 – Societe Generale, Andina de Fomento, Credit Real SAB de CV, Russian Railways, Teva Pharma, CRH, Aroundtown, Verizon – Financial Markets Blog
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
A1ZZHS | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,250 % bis 31.03.2023 | finanzen.net
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva amplía la emisión de pagarés de sostenibilidad a $5.000 millones
printmgr file
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
The Complexities of ESG Bonds | ESG Investing
PFA Pension, erhvervsobligationer
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 20-F TEVA PHARMACEUTICAL INDUSTRIES LIMITED